LIPA, lipase A, lysosomal acid type, 3988

N. diseases: 130; N. variants: 50
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.130 Biomarker disease BEFREE LAL activity can be considered a non-invasive new marker of cryptogenic liver fibrosis with higher accuracy than other known biomarkers. 31113613 2020
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.130 AlteredExpression disease BEFREE However, the relationship between LAL activity and liver fibrosis has never been investigated. 31392821 2019
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.130 Biomarker disease BEFREE LAL deficiency (LAL D) presents and progresses as a continuum with dyslipidemia, hepatomegaly, and liver fibrosis. 26350820 2016
CUI: C0239946
Disease: Fibrosis, Liver
Fibrosis, Liver
0.130 Biomarker disease HPO